The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 154.60
Bid: 154.00
Ask: 155.00
Change: -1.40 (-0.90%)
Spread: 1.00 (0.649%)
Open: 157.80
High: 157.80
Low: 150.00
Prev. Close: 156.00
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 May 2022 07:00

RNS Number : 6613M
Sabre Insurance Group PLC
25 May 2022
 

25 May 2022

 

Trading Update

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 January 2022 to 30 April 2022 ahead of its Annual General Meeting ("AGM") later this morning.

 

Key Highlights

- Gross written premium for the four months to 30 April 2022 30% ahead of the comparative prior-year period at £59.8m (2021: £46.0m)

- Gross written premium on the motor book slightly ahead year-on-year at £47.8m, in-line with our expectation while market conditions remain soft

- Additionally, we have written approximately £12.0m of motorcycle business which, given the expected seasonality, supports our previously stated outlook of circa £20m of motorcycle premium for the year

- Price increases of 12% for the year to the end of May, which we believe to be materially ahead of the market, reflecting our focus on maintaining profitability over volume

- Relationship with Freeway has brought in over £2m of premium on the taxi account this year - we estimate this will increase to around £16m by the year end

- Policy count 327k as at 30 April 2022 (30 April 2021: 276k), including 45k motorcycle policies (30 April 2021: nil)

- Continue to expect a significant correction to market pricing as inflation materially exceeds market price increases

- Overall post-dividend excess capital has reduced to 160% as at 31 March 2022, from 164% as at 31 December 2021, reflecting the expected capital strain resulting from the rapid growth in the business

- Continue to estimate claims inflation of at least 10%

- Expect combined ratio for the full-year to be around 80%, depending on the level of growth strain in motorcycle and taxi and current high levels of inflation

 

Business Update

As previously disclosed, market pricing increased in the early part of January in response to the General Insurance Pricing Practices review (which banned differential pricing on new business and renewals). We saw growth in our core portfolio during this period. More recently, the broader macro inflationary pressures have not been reflected in price increases across the market, which has modestly impacted our own private car volumes as we continued to exercise our own disciplined pricing strategy. The ongoing trend of lower new car purchases has continued, as anticipated, which continued to impact the size of our addressable market.

 

We are pleased with the impact made by the partnerships in Taxis (Freeway) and motorcycles (MCE and Bennetts). The integration of the three partnerships - and the flow of sales - has gone very well. Looking forward, diversifying the different types of business that Sabre insures makes the overall business more robust and provides more opportunities for growth without compromising on our disciplined growth strategy.

 

Outlook

We are encouraged by the outlook for the business. The addition of motorcycle and significant enhancement of taxi lines diversifies Sabre's growth opportunities and makes the overall business more robust. Alongside the additional growth from the taxi and motorcycle lines, we anticipate a benefit from pricing tailwinds for our core business which should be more positive for Sabre than our competitors because of our continued discipline in this area over the last few years. We also expect our addressable market to increase as new drivers return to the market and the supply of new cars starts to improve - although we anticipate that there may be a short-term decline in demand due to increased cost of living.

 

Overall, we continue to project material top-line growth this year across our combined product lines. Our financial-year combined operating ratio will be impacted by temporary growth strain in motorcycle and taxi, and the current high levels of inflation will need to be considered in evaluating the expected costs of open claims. However, we continue to target an 80% or better combined operating ratio on all policies we write, which is underpinned by significant rate increases this year.

 

Geoff Carter, Chief Executive Officer of Sabre, commented:

"2022 is shaping up to be the start of a more positive period for Sabre. Our expansions into the taxi and motorcycle markets have thus far promoted growth, and we are confident this will continue as we work on development initiatives with our new partners. Whilst we have seen a modest reduction in the policy count of the motor book in recent weeks as we await a strong positive correction in market pricing and continue to push price to counter claims inflation, we expect that things will further improve as new drivers return to the market, car sales pick up, and most importantly some competitors reflect the reality of extremely high claims inflation in pricing. Given this we expect to deliver good overall growth and a COR around our long-term target.

 

We are confident our disciplined pricing strategy in FY2021, which continues in 2022, will consolidate our core strengths whilst also allowing sustainable growth in new areas"

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Tulchan Communications

sabre@tulchangroup.com

James Macey White

Guy Bates

 

LEI Code: 2138006RXRQ8P8VKGV98

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFMLEESESI
Date   Source Headline
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.